# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Cantor Fitzgerald analyst Sarah James reiterates Tenet Healthcare (NYSE:THC) with a Overweight and maintains $112 price target.
Deutsche Bank analyst Pito Chickering maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $150...
JP Morgan analyst Lisa Gill maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $107 to...
Deutsche Bank analyst Pito Chickering maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $126...
Baird analyst Michael Ha initiates coverage on Tenet Healthcare (NYSE:THC) with a Outperform rating and announces Price Targ...